Isn’t the FDA involved in defining acceptable success criteria for trials?
I know no details on this company or it’s trial but they said they met all of their endpoints. Unless the data has been discovered to be suspect, it seems pretty disingenuous to say at this point that the efficacy is not good enough.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.